Tests Offered
Clinical Oncology
- NEW! Breast Cancer Molecular Classification
- NEW! HER2 positive Confirmatory Test
Health care providers require fast, reliable and robust answers to guide patient treatment decisions. We offer diagnostic services to meet your needs and develop laboratory based testing (LBT) services to solve current gaps in the diagnostic field. Biotech Innovations Ltd offers companion diagnostic tests (IVD-CDx) essential for the safe and effective use of a specific therapeutic product. The use of an IVD-CDx tests are stipulated in the instructions for use in the labeling of therapeutic products. Our technology platforms support real-time PCR, droplet digital-PCR, Next Generation Sequencing (NGS), and Luminex assays.
A digitalised HER2 test is developed as an LBT service and currently investing in commercialisation to reach your diagnostic labs. Using our optimised Innoplex system we offer multiplex assays for clinical diagnostics. In addition we also serve the academic research area with research use only reagents and becoming our partner in developing new test protocols is embraced by our professional research department.
Clinical Portfolio
HER2 positive confirmatory test
Microsatellite instability (MSI) in tumour samples.
PGx: Companion diagnostics including KRAS, BRAF, EGFR, NRAS, ALK, ROS1, RET, MET, and others.
PGx: Drug Therapy management including DPYD, UGT1A1, CYP2D6, CYP2C19.
Early diagnosis of Colorectal cancer
Diagnosis of Gastro Intestinal stromal tumours (GIST)
Diagnosis of Leukemias
NGS carrier screening
NGS newborn genetic screening
NGS Hereditary Cancer Screening
NGS Cancer Therapy prediction panels
NGS Targeted Drug Therapy panel
Companion diagnostic testing for clinical trials
Infectious: HPV genotyping and qPCRs for pathogen testing
HLA Typing
Coming soon: Non invasive prenatal screening
Academic portfolio
Innoplex: Breast Cancer Molecular Classification assay
NGS Cancer precision medicine
NGS exome sequencing
Contract Research in Oncology using our facilities. Facilities include Laser microdissection microscopy, real time PCR, digital droplet PCR, Luminex LX200, Luminex Magpix, Luminex Flexmap, immunohistology facility, histology slide scanner, cell culturing facilities, and facilities RNA, DNA and protein work.
Quality Control
If you need a third party to help you develop your internal quality control system, possibly even leading to certification, contact us.
R&D Services
Biotech Innovations offers mulitplex biomarker testing services for research institutes utilising all types of patient-derived material, including FFPE material (patient-derived and xenografts), liquid biopsies, tumour biopsies and cells. The multiplex assays can also be used for retrospective studies utilising clinicaly-annotated patient FFPE archival material, allowing fast biomarker validation.
Biotech Innovations research network also provides contract research to Diagnostic companies to use existing and develop new technologies towards providing solutions to fill market gaps. The diagnostic services at Biotech Innovations might already provide a solution to diagnostic companies, so get in contact to structure research projects towards translation to the clinic.